Isolation and Characterization of a Hepatoma ... - Cancer Research

fetoprotein over 80% of patients with hepatomas can be iden
tified with high certainty (10). HAPT, measured by immunoassay,
will provide an important new tool to survey populations
at risk for hepatocellular carcinoma and to monitor treatment.
ACKNOWLEDGMENTS
I am grateful for the support and helpful discussion of Dr. Bruce and
Barbara Furie. I wish to thank Dr. Myron Tong for providing patient
blood and ascites fluid. I also thank John Toomey for his excellent
technical assistance.
REFERENCES
1. Olson, J. P.. Miller, L. L., and Troup, S. B. Synthesis of clotting factors by
the isolated perfused rat liver. J. Clin. Invest., 45: 690-701, 1966.
2. Stenflo, J., Fernlurd, P., Egon, W., and RoepstorifT, P. Vitamin K-dependent
modification of glutamic acid residues in prothrombin. Proc. Nati. Acad. Sci.
USA, 71:2730-2733, 1974.
3. Nelsestuen, G. L., Zythuvicz, T. H., and Howard. J. B. The mode of action
of vitamin K: identification of -y-carboxyglutamic acid as a component of
prothrombin. J. Biol. Chem., 249: 6347-6350, 1974.
4. Wallin, R.. and Prydz, H. Studies on a subcellular system for vitamin Kdependent
carboxylation. Thromb. Haemost., 41: 529-536, 1979.
5. Sperling, R., Furie, B. C., Blumenstein, M., Keyt, B., and Furie, B. Metal
binding properties of -y-carboxyglutamic acid: implications for the vitamin
K-dependent blood coagulation proteins. J. Biol. Chem., 253: 3898-3906,
1978.
6. Ganrot, P. O.. and Nilehn J.-E. Plasma prothrombin during treatment with
dicumerol. II. Demonstration of an abnormal prothrombin fraction. Scand.
J. Clin. Lab. Invest., 22: 23-28, 1968.
7. Nelsestuen. G. L.. and Suttie, J. W. The purification and properties of an
abnormal prothrombin protein produced by dicumarol-treated cows: a com
parison to normal prothrombin. J. Biol. Chem., 247: 8176-8182, 1972.
8. Blanchard, R. A., Furie, B. C., Jorgensen, M., Kruger, S. F., and Furie, B.
Acquired vitamin K-dependent carboxylation deficiency in liver disease. N.
Engl. J. Med., 305: 242-248, 1981.
9. Blanchard, R. A., Furie, B. C„Kruger, S. F., Wanech, G., Jorgensen, M. J.,
and Furie, B. Immunoassays of human prothrombin species which correlate
with functional coagulant activities. J. Lab. Clin. Med., 101: 242-255, 1983.
10. Liebman, H. A., Furie. B. C, Tong, M. J., Blanchard, R. A., Lo, K-J., Lee,
S-D., Coleman, M. S.. and Furie, B. Des-7-carboxy (abnormal) prothrombin
as a serum marker of primary hepatocellular carcinoma. N. Engl. J. Med.,
310: 1427-1431, 1984.
11. Soulier, J-P., Grozin. D., and Lefrere, J-J. A new method to assay des-7carboxy
prothrombin. Results obtained in 75 cases of hepatocellular carci
noma. Gastroenterology, 91: 1258-1262, 1986.
12. Okuda, H., Obota, H.. Nakanishi, T., Furukawa, R., and Hashimoto, E.
CHARACTERIZATION OF A HEPATOMA ABNORMAL PROTHROMBIN
6497
Production of abnormal prothrombin (des--y-carboxy prothrombin) by hep
atocellular carcinoma: a clinical and experimental study. J. Hepatol.. 4: 357-
363, 1987.
13. Fujiyama, S. Morishita. T., Hashiguchi, O., and Sato. T. Plasma abnormal
prothrombin (des-7-carboxy prothrombin) as a marker of hepatocellular
carcinoma. Cancer (Phila.), 61: 1621-1628, 1988.
14. Rosenberg, J. S., Becker, D. L., and Rosenberg, R. D. Activation of human
prothrombin by purified human Factors V and Xa in the presence of an
antithrombin. J. Biol. Chem.. 250: 1607-1617, 1974.
15. Miletich, J. P., Jackson, C. M., and Majerus, P. W. Properties of the Factor
Xa binding site on human platelets. J. Biol. Chem. 253: 6908-6916, 1978.
16. Liebman, H. A., Limentani, S. A., Furie, B. C., and Furie, B. Immunoaffinity
purification of factor IX (Christmas factor) by using conformation-specific
antibodies directed against the factor IX-metal complex. Proc. Nati. Acad.
Sci. USA, 82: 3879-3893, 1985.
17. Borowski, M., Furie, B. C., Goldsmith, G. H., and Furie, B. Metal and
phospholipid binding properties of partially carboxylated human prothrom
bin variants. J. Biol. Chem., 260: 9258-9264, 1985.
18. Laemmli. U. K. Cleavage of structural proteins during assembly of the head
of bacteriophage T4. Nature (Lond.), 227: 680-685. 1970.
19. Davis, B. J. Disc electrophoresis. II. Method and application to human serum
proteins. Ann. NY Acad. Sci., 121: 404-427, 1964.
20. Morrison, M. Lactoperoxidase-catalyzed iodination as a tool for investigation
of proteins. Methods Enzymol., 70: 214-222, 1980.
21. Fohlman, J., Rash, L.. and Peterson, P. A. High-pressure liquid Chromato
graphie identification of phenylthiohydantoin derivatives of all twenty com
mon amino acids. Anal. Biochem.. 106: 22-26, 1980.
22. Kuwada, M., and Katayama, K. An improved method for determination of
7-carboxyglutamic acid in proteins, bone and urine. Anal. Biochem.. 131:
173-179, 1983.
23. Diuguid, D. L., Rabiet, M. M., Furie, B. C., Liebman. H. A., and Furie, B.
Molecular basis of hemophilia B: a defective enzyme due to an unprocessed
propeptide is caused by a point mutation in the factor IX precursor. Proc.
Nati. Acad. Sci. USA, 83: 5803-5807, 1986.
24. Waxman, S., Liu, C-K., and Schmied, R. Abnormal glycoproteins and
glycosyltransferases in human hepatoma. Ann. NY Acad. Sci.. 349: 411-
420, 1980.
25. Malhotra, O. P. Purification and characterization of dicoumarol-induced
prothrombin. Barium citrate atypical (7-Gla) prothrombin. Thromb. Res.,
15:427-437, 1979.
26. Malhotra, O. P. Purification and characterization of dicoumarol-induced
prothrombin. II. Barium oxalate atypical (5-Gla) variant. Thromb. Res., 15:
439-448, 1979.
27. Waldmann, T. A., and Mclntire, K. R. The use of a radioimmunoassay for
«-fetoprotein in the diagnosis of malignancy. Cancer (Phila.), 34: 1510-
1515, 1974.
28. Sanier, M. A., Waldmann, T. A., and Fallón, H. J. Erythrocytosis and
hyperlipemia as manifestations of hepatic carcinoma. Arch. Intern. Med.,
120: 735-739. 1967.
29. Gralnick, H. R., Giuelber. H., and Abrams, E. Disfibrinogenemia associated
with hepatoma: increased carbohydrate content of the fibrinogen molecule.
N. Engl. J. Med., 299: 221-226, 1978.
30. Shah, D. V.. Engelke. J. A., and Suttie, J. W. Abnormal prothrombin in the
plasma of rats carrying hepatic tumors. Blood, 69: 850-854, 1987.
Downloaded from
cancerres.aacrjournals.org on July 30, 2013. © 1989 American Association for Cancer Research.